RE-EVALUATION OF GENEXPERT AND EUTOS METHODS FOR THE MONITORING OF CHRONIC MYELOID LEUKEMIA (CML)

被引：0
|
作者：
Maria de las Nieves, Saez Perdomo [1 ]
Ortega Yanira, Florido [1 ]
Rodriguez Ramon, Reyes [1 ]
Santana Guillermo, Santana [1 ]
Henriquez Hugo, Luzardo [1 ]
Jose David, Gonzalez San Miguel [2 ]
Maria Teresa, Gomez Casares [1 ]
Maria Teresa, Molero Labarta [1 ]
机构：
[1] Hosp Univ Gran Canaria Dr Negrin, Las Palmas Gran Canaria, Las Palmas, Spain
[2] Complejo Hosp Univ Insular Materno Infantil, Las Palmas Gran Canaria, Las Palmas, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC 278
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
  • [1] Molecular monitoring in chronic myeloid leukemia (CML)
    Izzo, Barbara
    Accetta, Raffaella
    Caruso, Simona
    De Angelis, Biagio
    Del Prete, Ciro
    Errichiello, Santa
    Galdiero, Alessandra
    Casadei, Giada Muccioli
    Musella, Filomena
    Quintarelli, Concetta
    Visconti, Roberta
    Pane, Fabrizio
    BIOCHIMICA CLINICA, 2015, 39 (02) : 94 - 99
  • [2] EVALUATION OF BCR-ABL MONITORING IN CHRONIC MYELOID LEUKEMIA (CML) IN CLINICAL PRACTICE
    Romvari, Edie
    Bollu, Vamsi
    Morlock, Robert
    Teitelbaum, April
    Henk, Henry
    Garcia, Reynaldo
    ONCOLOGY NURSING FORUM, 2011, 38 (02) : E160 - E161
  • [3] THE NEW EUTOS SCORE HAS PROGNOSTIC VALUE IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) OUTSIDE CLINICAL TRIALS
    Casado Montero, L. F.
    Garcia-Gutierrez, V.
    Maestro, B.
    Massague, I.
    Giraldo, P.
    Perez-Encinas, M.
    De Paz, R.
    Martinez-Lopez, J.
    Bautista, G.
    Osorio, S.
    Requena, M. J.
    Palomera, L.
    Penarrubia, M. J.
    Dumas, M. H.
    Garcia-Ormena, N.
    Calle, C.
    Hernandez-Rivas, J. A.
    Steegmann, J. L.
    HAEMATOLOGICA, 2012, 97 : 310 - 310
  • [4] Chronic myeloid leukemia (CML) in 2012
    Michallet, M.
    ONCOLOGIE, 2012, 14 (10-11) : 559 - 560
  • [5] APPLICATION OF THE EUTOS SCORE IN A SERIES OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE (CP) TREATED WITH TYROSIN KINASE INHIBITORS (TKI)
    Xicoy, B.
    Boque, C.
    Fernandez, C.
    Vallansot, R.
    Cortes, M.
    Ortin, X.
    Rodriguez, L.
    Plensa, E.
    Buch, J.
    Marce, S.
    Garcia, O.
    Velez, P.
    Abenoza, L.
    Miguel, L.
    de Sevilla, A.
    Grau, J.
    Estrada, N.
    Ribera, J.
    HAEMATOLOGICA, 2013, 98 : 552 - 552
  • [6] Cytogenetic monitoring of patients with chronic myeloid leukemia (CML), undergoing Gleevec treatment
    Zedginidze, Alla
    Vatsadze, Tea
    Gvimradze, Khatuna
    CHROMOSOME RESEARCH, 2007, 15 : 207 - 208
  • [7] Cytogenetic monitoring of patients with chronic myeloid leukemia (CML), undergoing gleevec treatment
    Zedginidze, A.
    Vatsadze, T.
    Gvimradze, Kh.
    CHROMOSOME RESEARCH, 2007, 15 : 216 - 217
  • [8] BURKITTS LEUKEMIA - A RE-EVALUATION
    MINERBROOK, M
    SCHULMAN, P
    BUDMAN, DR
    TEICHBERG, S
    VINCIGUERRA, V
    KARDON, N
    DEGNAN, TJ
    CANCER, 1982, 49 (07) : 1444 - 1448
  • [9] Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform
    Valent, Peter
    Lion, Thomas
    Wolf, Dominik
    Sillaber, Christian
    Agis, Hermine
    Petzer, Andreas
    Lang, Alois
    Kalhs, Peter
    Geissler, Dietmar
    Greil, Richard
    Linkesch, Werner
    Burgstaller, Sonja
    Thaler, Josef
    Gastl, Gunther
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (21-22) : 697 - 709
  • [10] Correlation of three methods of measuring cytogenetic response in chronic myeloid leukemia (CML).
    Lesser, ML
    DeWald, G
    Sison, CP
    Silver, RT
    BLOOD, 2000, 96 (11) : 111A - 111A
12345